InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by MITCHELL DEAN J, Director. Officer active across 4 companies, notably ImmunoGen, Inc.. In total, 6 disclosures have been published. Total volume traded: €42k. The latest transaction was filed on 8 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€42,16225,000 shares@ €1.68650.0006% mcap100.0% of flow
Common Stock
SEC:0001689548-22-000075:0·
Ideal exit: 5 Mar 2023 (T+270)
09,852 shares0
Ordinary Shares
SEC:0001415889-22-004332:0·
16,212 shares
Common Stock
SEC:0000950103-22-005401:0·
€49,95627,832 shares@ €1.79490.0032% mcap100.0% of flow
Common Stock
SEC:0000950103-22-003222:0·
€7,7465,000 shares@ €1.5493100.0% of flow
Common Stock
SEC:0001179110-21-008587·
€7,7465,000 shares@ €1.549350.0% of flow
Common Stock
SEC:0001179110-21-008587:0·
6 of 6 declarations
About MITCHELL DEAN J
Dean J. Mitchell is a Board Member at ImmunoGen, Inc., PRECIGEN, INC., and Theravance Biopharma, Inc. He plays a vital role in the governance of these companies, bringing his expertise in biopharmaceuticals and innovation. Mitchell contributes to formulating strategies that promote growth and sustainable development.
